US Stock MarketDetailed Quotes
STAB Statera Biopharma
- 0.000700
- 0.0000000.00%
15min DelayClose Apr 24 16:00 ET
49.99KMarket Cap0.00P/E (TTM)
0.000700High0.000700Low5.00KVolume0.000700Open0.000700Pre Close3.50Turnover0.01%Turnover Ratio0.00P/E (Static)71.42MShares0.03800052wk High0.00P/B44.69KFloat Cap0.00000152wk Low--Dividend TTM63.84MShs Float279.800000Historical High--Div YieldTTM0.00%Amplitude0.000001Historical Low0.000000Avg Price1Lot Size
Statera Biopharma Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | (FY)Dec 31, 2021 | (Q4)Dec 31, 2021 | (Q3)Sep 30, 2021 | (Q2)Jun 30, 2021 | (Q1)Mar 31, 2021 | (FY)Dec 31, 2020 | (Q4)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | 46.09%169.35K | 200.94K | 353.67K | 488.31K | 372.39K | 115.93K | 0 | 0 | 0 | 0 |
| Gross profit | -46.09%-169.35K | -200.94K | -353.67K | -488.31K | -372.39K | -115.93K | 0 | 0 | 0 | 0 |
| Operating expense | -85.07%1.3M | -57.89%2.54M | 18.41%6.04M | 164.27%28.83M | 106.83%9M | 46.18%8.69M | 6.03M | 4,459.06%5.1M | 287.65%10.91M | 4.35M |
| Selling and administrative expenses | -68.37%1.74M | -44.60%2.33M | -6.89%3.8M | 227.46%18.49M | 30.55%4.7M | 251.41%5.49M | --4.21M | 4,759.58%4.08M | 153.48%5.65M | --3.6M |
| -Selling and marketing expense | -42.56%13.35K | --19.36K | 1,224.61%37.04K | 3,201.70%79.44K | 2,119.53%53.4K | --23.24K | --0 | --2.8K | --2.41K | --2.41K |
| -General and administrative expense | -68.48%1.72M | -45.06%2.32M | -7.73%3.76M | 226.19%18.41M | 29.16%4.65M | 249.93%5.47M | --4.21M | 4,756.25%4.08M | 153.37%5.64M | --3.6M |
| Research and development costs | -93.29%230.6K | -46.38%973.6K | 216.53%3.24M | 124.75%11.83M | 636.84%5.56M | -21.64%3.43M | --1.82M | 3,558.37%1.02M | 796.73%5.26M | --753.94K |
| Other operating expenses | -183.48%-670.47K | ---768.83K | ---997.84K | ---1.49M | ---1.25M | ---236.52K | ---- | ---- | ---- | ---- |
| Operating profit | 83.34%-1.47M | 54.55%-2.74M | -25.34%-6.4M | -168.74%-29.32M | -115.38%-9.38M | -48.13%-8.81M | -6.03M | -4,459.06%-5.1M | -287.65%-10.91M | -4.35M |
| Net non-operating interest income expense | 41.40%-1.81M | -126.18%-637.04K | -1,137.77%-1.15M | -303.31%-4.56M | -1,689.16%-1.1M | -728.14%-3.09M | -281.66K | -155.91%-92.62K | -810.14%-1.13M | -61.29K |
| Non-operating interest expense | -41.40%1.81M | 126.18%637.04K | 1,137.77%1.15M | ---- | ---- | --3.09M | --281.66K | 155.91%92.62K | ---- | ---- |
| Total other finance cost | ---- | ---- | ---- | 303.31%4.56M | ---- | ---- | ---- | ---- | 810.14%1.13M | --61.29K |
| Other net income (expense) | 90.52%-79.18K | 61.45%-113.08K | -138.20%-218.14K | -11,623.63%-68M | -19,466.73%-66.78M | -273.15%-835.15K | -293.33K | 81.68%-91.58K | -103.07%-580K | -341.28K |
| Special income (charges) | 90.52%-79.18K | 61.45%-113.08K | -138.20%-218.14K | -11,623.63%-68M | -19,466.73%-66.78M | -273.15%-835.15K | ---293.33K | ---91.58K | ---580K | ---341.28K |
| -Less：Restructuring and merger&acquisition | -90.52%79.18K | -61.45%113.08K | 138.20%218.14K | 1,102.62%1.43M | 270.58%205.07K | 273.15%835.15K | --293.33K | --91.58K | --118.5K | ---120.22K |
| -Less:Other special charges | ---- | ---- | ---- | -322.92%-1.03M | ---- | ---- | ---- | ---- | --461.5K | ---- |
| -Write off | ---- | ---- | ---- | --67.6M | ---- | ---- | ---- | ---- | --0 | ---- |
| Income before tax | 73.64%-3.36M | 47.15%-3.49M | -46.78%-7.76M | -707.26%-101.88M | -1,524.27%-77.25M | -124.22%-12.73M | -6.61M | -715.70%-5.29M | -291.43%-12.62M | -4.76M |
| Income tax | ||||||||||
| Net income | 73.64%-3.36M | 47.15%-3.49M | -46.78%-7.76M | -742.37%-101.88M | -1,726.25%-77.25M | -124.22%-12.73M | -6.61M | -715.70%-5.29M | -275.12%-12.09M | -4.23M |
| Net income continuous Operations | 73.64%-3.36M | 47.15%-3.49M | -46.78%-7.76M | -707.26%-101.88M | -1,524.27%-77.25M | -124.22%-12.73M | ---6.61M | -715.70%-5.29M | -291.43%-12.62M | ---4.76M |
| Net income discontinuous operations | --0 | --0 | --0 | --1 | --0 | --1 | --0 | --0 | --0 | --0 |
| Minority interest income | 39.62%-8.1K | -3.15K | -2.72K | -24.35K | -10.93K | -13.42K | 0 | 0 | 0 | 0 |
| Net income attributable to the parent company | 73.67%-3.35M | 47.20%-3.49M | -46.73%-7.76M | -742.17%-101.85M | -1,725.99%-77.24M | -123.99%-12.72M | -6.61M | -715.70%-5.29M | -275.12%-12.09M | -4.23M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 73.67%-3.35M | 47.20%-3.49M | -46.73%-7.76M | -742.17%-101.85M | -1,725.99%-77.24M | -123.99%-12.72M | -6.61M | -715.70%-5.29M | -275.12%-12.09M | -4.23M |
| Basic earnings per share | 85.11%-0.07 | 72.82%-0.07 | 2.96%-0.2 | -515.06%-2.9 | -1,219.92%-2.1767 | -112.29%-0.47 | -0.2575 | -715.69%-0.2061 | -275.12%-0.4715 | -0.1649 |
| Diluted earnings per share | 85.11%-0.07 | 72.82%-0.07 | 2.96%-0.2 | -515.06%-2.9 | -1,219.92%-2.1767 | -112.29%-0.47 | -0.2575 | -715.69%-0.2061 | -275.12%-0.4715 | -0.1649 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg